The Innovative Translational Research Shared Resource (ITR) partners with oncologists and laboratory and non-laboratory researchers to guide, manage, and facilitate pre-clinical and clinical trial laboratory discoveries.
VICC Home > Research > Shared Resources > VICC
Innovative Translational Research > & nbspVICC
Innovative Translational Research Shared Resource
Not exact matches
Focusing on basic
research for the functional regulation of innate and adaptive immunity and on
translational research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting
innovative research and exploration, and is becoming a rising star in the international immunology community.
«This is expected to be the first of many new
innovative therapies made possible by the Wyss Institute's collaborative model of
translational research that will enter human clinical trials,» said Wyss Founding Director Don Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and a Professor of Bioengineering at Harvard SEAS.
In addition, CVI researchers are at the forefront of cutting - edge cardiac
translational research, bringing
innovative treatments from the lab to the patient.
Cross funded by AFM - Téléthon and INSERM in 2005, I - Stem also joined the AFM - Téléthon Biotherapies Institute for Rare Diseases last 2012 which is an unrivalled strike force and a world reference hub in
translational biomedical
research and
innovative medicines.
The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most
innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and
translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.
Breast Cancer
Research Foundation - AACR Career Development Award for
Translational Breast Cancer
Research Mary Kay Foundation
Innovative Translational Grant Award Department of Defense Breast
Research Program Breakthrough Award
The goal is to reward scientific excellence and to encourage
innovative research in lung cancer prevention and
translational medicine.
She Chairs the Scientific Advisory Board (SAB) of NASA's
Translational Research Institute (TRI) at Baylor College of Medicine in Houston, charged with
researching and developing
innovative approaches to reduce risks to humans on long - duration exploration missions, including NASA's Journey to Mars.
Theranostics publishes
innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image - guided therapy, biosensors, system biology and
translational medicine, personalized medicine and a broad spectrum of biomedical
research that can be applied to future theranostic applications.
Nanotheranostics publishes
innovative and original basic,
translational and clinical
research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and other areas.
In addition, I work closely with colleagues in Lineberger on
innovative clinical trials and
translational research projects directed at developing novel strategies for the treatment of advanced disease.
Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly
innovative pilot projects focusing on proof - of - concept or
translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant awards or clinical trial; (3) projects that closely align with the Cancer Center's strategic plan and enhance key initiatives; and (4) pilot funding for junior investigators to jump - start independent projects or for more senior investigators looking to study a novel idea derived from discovery.